Key players in Lung Cancer Therapeutics
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Merck & Co., Inc. |
merck.com (opens in a new tab) | 1,320 reports |
| 2 |  AstraZeneca |
astrazeneca.com (opens in a new tab) | 957 reports |
| 3 |  Roche |
roche.com (opens in a new tab) | 1,485 reports |
| 4 |  Bristol-Myers Squibb |
bms.com (opens in a new tab) | 627 reports |
| 5 |  Amgen Inc. |
amgen.com (opens in a new tab) | 693 reports |
| 6 |  Johnson & Johnson |
jnj.com (opens in a new tab) | 2,376 reports |
Also active in Lung Cancer Therapeutics
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
 Novartis AG |
|
| Jiangsu Hansoh Pharmaceutical Co., Ltd. |
|
 Eli Lilly and Company |
|
| Mylan N.V. | |
| Hospira Inc | |
 Fresenius SE & CO |
|
| Sichuan Baili Pharmaceutical Co., Ltd. |
|
| Accord Healthcare | |
 Hikma Pharmaceuticals PLC |
|
 Pfizer Inc. |
|
| Meitheal | |
| Sandoz |
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Top trial sponsors in Lung Cancer Therapeutics
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- AstraZeneca 79 active trials on ClinicalTrials.gov (opens in a new tab)
- Merck & Co., Inc. 31 active trials on ClinicalTrials.gov (opens in a new tab)
- Sichuan Baili Pharmaceutical Co., Ltd. 22 active trials on ClinicalTrials.gov (opens in a new tab)
- Bristol-Myers Squibb 19 active trials on ClinicalTrials.gov (opens in a new tab)
- Johnson & Johnson 17 active trials on ClinicalTrials.gov (opens in a new tab)
- Amgen Inc. 15 active trials on ClinicalTrials.gov (opens in a new tab)
- Pfizer Inc. 15 active trials on ClinicalTrials.gov (opens in a new tab)
- Jiangsu Hansoh Pharmaceutical Co., Ltd. 14 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Lung Cancer Therapeutics reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Lung Cancer Therapeutics report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.